Alkaline Phosphatase (ALPL) Antibody (N-term) Blocking peptide

DETAILS

Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Gene Id: 249
Category: Peptides; Blocking Peptides
Subtitle: Synthetic peptide
Gene Name: ALPL
Other Names: Alkaline phosphatase, tissue-nonspecific isozyme, AP-TNAP, TNSALP, Alkaline phosphatase liver/bone/kidney isozyme, ALPL
Availability: 2 weeks
Bio Background: There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The genes for the first three are located together on chromosome 2 while the tissue non-specific form is located on chromosome 1. This protein is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. The exact physiological function of the alkaline phosphatases is not known. A proposed function of this form of the enzyme is matrix mineralization, however, mice that lack a functional form of this enzyme show normal skeletal development. This enzyme has been linked directly to a disorder known as hypophosphatasia, a disorder that is characterized by hypercalcemia and includes skeletal defects. The character of this disorder can vary, however, depending on the specific mutation since this determines age of onset and severity of symptoms.
Bio References: Panuccio,V., Am. J. Kidney Dis. 50 (6), 1001-1008 (2007)Brun-Heath,I., Eur J Med Genet 50 (5), 367-378 (2007)So,P.P., J. Rheumatol. 34 (6), 1313-1322 (2007)
Primary Accession: P05186
Targetspecificity: The synthetic peptide sequence used to generate the antibody AP1474a was selected from the N-term region of human ALPL. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.